These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20217136)

  • 1. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
    Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
    Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
    Sawaji Y; Hynes J; Vincent T; Saklatvala J
    Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
    Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
    J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro.
    Voigt H; Lemke AK; Mentlein R; Schünke M; Kurz B
    Arthritis Res Ther; 2009; 11(5):R141. PubMed ID: 19778432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonal differences in meniscus matrix turnover and cytokine response.
    Fuller ES; Smith MM; Little CB; Melrose J
    Osteoarthritis Cartilage; 2012 Jan; 20(1):49-59. PubMed ID: 22062355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
    Chockalingam PS; Zeng W; Morris EA; Flannery CR
    Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecanolysis and in vitro matrix degradation in the immature bovine meniscus: mechanisms and functional implications.
    Wilson CG; Vanderploeg EJ; Zuo F; Sandy JD; Levenston ME
    Arthritis Res Ther; 2009; 11(6):R173. PubMed ID: 19919704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
    Stevens AL; Wheeler CA; Tannenbaum SR; Grodzinsky AJ
    Osteoarthritis Cartilage; 2008 Apr; 16(4):489-97. PubMed ID: 17923423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of mature meniscal tissue to a single injurious compression and interleukin-1 in vitro.
    Hufeland M; Schünke M; Grodzinsky AJ; Imgenberg J; Kurz B
    Osteoarthritis Cartilage; 2013 Jan; 21(1):209-16. PubMed ID: 23069857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts.
    Mladenovic Z; Saurel AS; Berenbaum F; Jacques C
    J Rheumatol; 2014 May; 41(5):945-54. PubMed ID: 24737908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions.
    Chan PS; Caron JP; Orth MW
    Am J Vet Res; 2007 Jul; 68(7):709-15. PubMed ID: 17605605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo.
    Madsen SH; Sumer EU; Bay-Jensen AC; Sondergaard BC; Qvist P; Karsdal MA
    Biomarkers; 2010 May; 15(3):266-76. PubMed ID: 20039789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
    Struglics A; Hansson M
    Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
    Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
    Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
    Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
    Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration.
    Patel KP; Sandy JD; Akeda K; Miyamoto K; Chujo T; An HS; Masuda K
    Spine (Phila Pa 1976); 2007 Nov; 32(23):2596-603. PubMed ID: 17978660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.
    Yatabe T; Mochizuki S; Takizawa M; Chijiiwa M; Okada A; Kimura T; Fujita Y; Matsumoto H; Toyama Y; Okada Y
    Ann Rheum Dis; 2009 Jun; 68(6):1051-8. PubMed ID: 18662930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term exposure of articular cartilage to curcumin or quercetin inhibits aggrecan loss.
    Lay E; Samiric T; Handley CJ; Ilic MZ
    J Nutr Biochem; 2012 Feb; 23(2):106-12. PubMed ID: 21419610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.